机译:乳腺上皮来源恶性肿瘤中HLA抗原的变化:分子机制和临床意义。
Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA;
Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA;
Basic Medical Science Division, Memorial University of Newfoundland, St. John's, Newfoundland & Labrador, Canada, A1B3V6;
Basic Medical Science Division, Memorial University of Newfoundland, St. John's, Newfoundland & Labrador, Canada, A1B3V6;
Basic Medical Science Division, Memorial University of Newfoundland, St. John's, Newfoundland & Labrador, Canada, A1B3V6;
Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA;
HLA class I antigens; HLA class II antigens; non-classical HLA class I antigens; NK cell activating ligands; breast cancer;
机译:犬乳腺上皮细胞成瘤过程中鳞状鳞状上皮细胞角蛋白的表达:I型(酸性)57 Kilodalton细胞角蛋白可能是乳腺上皮细胞恶性转化的分子标记
机译:类固醇激素模拟物:正常和恶性乳腺上皮细胞中细胞生长和凋亡的分子机制。
机译:人乳头瘤病毒病毒炎病毒炎症和分子失调的调节机制:乳腺癌的影响
机译:AG或UAG对奶牛乳腺上皮细胞β-酪蛋白表达的影响及其分子机制
机译:骨骼肌钙释放信道介导的恶性热疗介导的系统热调节的分子机制及临床意义
机译:LNCRNA MNX1-AS1在恶性肿瘤中的临床疗效和分子机制
机译:肿瘤中HLA类II抗原加工途径:分子缺陷和临床相关性
机译:交叉反应性人组织相容性抗原HLa-a28和HLa-a2的结构:可能对HLa多态性的产生有影响。